1. Mimouni F., Tsang R.C. Parathyroid and vitamin D-related disorders. In: Kaplan S.A. (Ed.), Clinical Pediatric Endocrinology. W.B. Saunders Company, Philadelphia, 1990, p. 427–453.
2. Demarini S., Tsang R.C. Disorders of calcium and magnesium metabolism. In: Fanaroff A.A., Martin R.J. (Eds.), Neonatal-perinatal medicine. Mosby-Year Book, Inc., St. Louis, 1992, p. 1181–1198.
3. Pearce S.H., Trump D., Wooding C., Besser G.M., Chew S.L., Grant D.B., Heath D.A., Highes I.A., Paterson G.R., Whytem S. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J. Clin. Invest. 1995, 96: 2683–2692.
4. Bai M., Pearce S.H., Kifor O., Trivedi S., Stauffer U.G., Thakker R.V., Brown E.M., Steinmann B. In vivo and in vitro characterization of neonatal hy-perparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J. Clin. Invest. 1997, 99: 88–96.
5. Aarskog D., Harrison H. Disorders of calcium, phospate, PTH and vitamin D. In: Kappy M.S., Blizzard R.M., Migeon C.J. (Eds.), The diagnosis and treatment of endocrine disorders in childhood and adolescence. Charles C Thomas Publisher, Springfield, 1994, p. 1027–1092.